Company news
Medicure Inc. news in 2023
Medicure Inc.'s news releases, calls and decks from 2023, newest first.
Medicure Announces New Partnership Through Its Marley Drug Subsidiary to Provide Brenzavvy(R) as an Affordable Medication for Americans with Type 2 Diabetes
December 5, 2023
Medicure Announces FDA Provides Complete Approval to Enroll Patients in Its Pivotal Phase 3 Trial for Treatment of Rare Pediatric Disease
November 23, 2023
Medicure Reports Financial Results for Quarter Ended September 30, 2023
November 21, 2023
Medicure Reiterates its Commitment to Providing Exceptional Access to its Branded Pitavastatin (Zypitamag) to People Living With HIV
August 29, 2023
Medicure Reports Financial Results For Quarter Ended June 30, 2023
July 28, 2023
Medicure to Present Financial Results on July 31, 2023 Call at 8: 30 AM ET for Quarter Ended June 30, 2023
July 24, 2023
Medicure Reports Financial Results for Quarter Ended March 31, 2023
May 26, 2023
Medicure Reports Financial Results for Quarter and Year Ended December 31, 2022
April 6, 2023
Medicure To Present Financial Results on April 10, 2023 Call at 8: 30 AM ET for Quarter and Year Ended December 31, 2022
April 5, 2023
Medicure announces resignation of board member and grant of stock options
February 1, 2023
Calls in 2023
Decks in 2023
- Investor Presentation (September 2023)
Investor deck · 15 slides · Sep 27, 2023
- Investor Presentation (April 2023)
Investor deck · 15 slides · April 2023